Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)

CNY 22.37

(-1.37%)

Net Debt Summary of Vcanbio Cell & Gene Engineering Corp., Ltd

  • Vcanbio Cell & Gene Engineering Corp., Ltd's latest annual net debt in 2023 was -1.46 Billion CNY , down -15.94% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd's latest quarterly net debt in 2024 Q2 was -1.33 Billion CNY , up 5.22% from previous quarter.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported annual net debt of -1.26 Billion CNY in 2022, down -12.34% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported annual net debt of -1.12 Billion CNY in 2021, down -11.01% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported quarterly net debt of -1.4 Billion CNY for 2024 Q1, up 3.79% from previous quarter.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported quarterly net debt of -1.33 Billion CNY for 2024 Q2, up 5.22% from previous quarter.

Annual Net Debt Chart of Vcanbio Cell & Gene Engineering Corp., Ltd (2023 - 1992)

Historical Annual Net Debt of Vcanbio Cell & Gene Engineering Corp., Ltd (2023 - 1992)

Year Net Debt Net Debt Growth
2023 -1.46 Billion CNY -15.94%
2022 -1.26 Billion CNY -12.34%
2021 -1.12 Billion CNY -11.01%
2020 -1.01 Billion CNY -104.25%
2019 -496.18 Million CNY -27.17%
2018 -390.17 Million CNY -430.36%
2017 -73.56 Million CNY 55.84%
2016 -166.59 Million CNY 66.33%
2015 -494.81 Million CNY -40.54%
2014 -352.08 Million CNY 56.87%
2013 -816.34 Million CNY -30.74%
2012 -624.39 Million CNY -6.4%
2011 -586.84 Million CNY -27.54%
2010 -460.11 Million CNY -41.27%
2009 -325.7 Million CNY -70.71%
2008 -190.79 Million CNY -249.19%
2007 -54.63 Million CNY -75.01%
2006 -31.22 Million CNY -183.22%
2005 37.51 Million CNY -15.44%
2004 44.36 Million CNY -16.45%
2003 53.09 Million CNY -12.97%
2002 61.01 Million CNY -67.17%
2001 185.84 Million CNY 80.91%
2000 102.72 Million CNY -17.58%
1999 124.64 Million CNY 4.05%
1998 119.78 Million CNY -7.55%
1997 129.56 Million CNY 80.64%
1996 71.72 Million CNY -22.02%
1995 91.97 Million CNY 31.43%
1994 69.97 Million CNY 307.27%
1993 17.18 Million CNY 44.77%
1992 11.86 Million CNY 0.0%

Peer Net Debt Comparison of Vcanbio Cell & Gene Engineering Corp., Ltd

Name Net Debt Net Debt Difference
Beijing Tiantan Biological Products Co., Ltd. -2.68 Billion CNY 45.447%
JiangSu WuZhong Pharmaceutical Development Co., Ltd. 81.56 Million CNY 1896.554%
Jinyu Bio-technology Co., Ltd. -1.7 Billion CNY 14.202%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 2.97 Billion CNY 149.179%
Zhejiang Ausun Pharmaceutical Co., Ltd. -711.3 Million CNY -106.011%
DaShenLin Pharmaceutical Group Co., Ltd. 6.25 Billion CNY 123.433%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. -3.41 Billion CNY 57.143%
GuiZhou SanLi Pharmaceutical Co.,Ltd 38.58 Million CNY 3897.634%
Pulike Biological Engineering, Inc. -315.16 Million CNY -364.957%
Beijing Konruns Pharmaceutical Co.,Ltd. -80.42 Million CNY -1722.107%
Shanghai Hile Bio-Technology Co., Ltd. -89.9 Million CNY -1529.863%
Qingdao Vland Biotech INC. 494.24 Million CNY 396.488%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. -755.56 Million CNY -93.943%
Aurisco Pharmaceutical Co.,Ltd. -428.95 Million CNY -241.614%
Zhejiang East Asia Pharmaceutical Co., Ltd. -4.19 Million CNY -34806.17%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 758.92 Million CNY 293.085%
Mabwell (Shanghai) Bioscience Co., Ltd. -358.25 Million CNY -309.032%
Beijing Hotgen Biotech Co., Ltd. -257.13 Million CNY -469.877%
Assure Tech (Hangzhou) Co., Ltd. -321.77 Million CNY -355.404%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 260.4 Million CNY 662.733%
Cabio Biotech (Wuhan) Co., Ltd. -226.91 Million CNY -545.781%
Shanghai Shen Lian Biomedical Corporation -43.72 Million CNY -3251.358%
Nanjing Vazyme Biotech Co., Ltd. -679.87 Million CNY -115.536%
Shandong Kexing Bioproducts Co,.Ltd 547.26 Million CNY 367.763%
Shanghai Junshi Biosciences Co., Ltd. -2 Billion CNY 26.8%
Shanghai Model Organisms Center, Inc. -2.84 Million CNY -51369.666%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. -1.22 Billion CNY -19.796%
Xiamen Amoytop Biotech Co., Ltd. -405.03 Million CNY -261.79%
Novogene Co., Ltd. -662.54 Million CNY -121.171%
Shanghai ZJ Bio-Tech Co., Ltd. -2.76 Billion CNY 46.946%
Chengdu Olymvax Biopharmaceuticals Inc. -124.46 Million CNY -1077.329%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd -883.23 Million CNY -65.909%
Shanghai Haohai Biological Technology Co., Ltd. -2.33 Billion CNY 37.164%
Jiangsu Bioperfectus Technologies Co., Ltd. -1.59 Billion CNY 8.18%
Jiangsu Aidea Pharmaceutical Co., Ltd. 186.94 Million CNY 883.851%
Chengdu Easton Biopharmaceuticals Co., Ltd. -557.74 Million CNY -162.729%
Sinocelltech Group Limited 2.45 Billion CNY 159.746%
Wuhan Keqian Biology Co.,Ltd -288.23 Million CNY -408.399%
Shanghai Allist Pharmaceuticals Co., Ltd. -1.86 Billion CNY 21.23%
Anhui Huaheng Biotechnology Co., Ltd. 893.66 Million CNY 263.972%
Youcare Pharmaceutical Group Co., Ltd. -1.01 Billion CNY -44.044%
Jiangsu gdk Biotechnology Co., Ltd. -6.38 Million CNY -22846.597%
Beijing Kawin Technology Share-Holding Co., Ltd. -798.7 Million CNY -83.467%
Hangzhou Biotest Biotech Co.,Ltd. -1.9 Billion CNY 23.053%